BioAtla (BCAB) EPS (Basic) (2020 - 2026)

BioAtla's (BCAB) quarterly EPS (Basic) came in at -$6.19 in Q1 2026, up 58.82% year-on-year from -$3.9 in Q1 2025, and up 20.72% quarter-over-quarter from -$7.8 in Q4 2025.

BioAtla (BCAB) EPS (Basic) (2020 - 2026) Analysis & Trends

BioAtla's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$6.19 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 58.82% year-over-year to -$6.19 in Q1 2026; TTM through Mar 2026 was -$39.97, a 31.33% increase from a year earlier, with the FY2025 full-year figure at -$148.22, up 16.88% from the prior year.
  • EPS (Basic) climbed to -$6.19 in Q1 2026 per BCAB's latest filing, from -$7.8 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$6.19 in Q1 2026 and bottomed at -$3677.7 in Q3 2022.
  • The 5-year median for EPS (Basic) is -$28.44 (2023), against an average of -$277.07.
  • Across the five-year window, EPS (Basic) plunged 10777.33% in 2022 and soared 99.03% in 2023, its largest moves.
  • Year by year, EPS (Basic) stood at -$35.85 in 2022, then increased by 20.69% to -$28.44 in 2023, then soared by 43.18% to -$16.16 in 2024, then soared by 51.7% to -$7.8 in 2025, then grew by 20.72% to -$6.19 in 2026.
  • Per Business Quant, the three latest BCAB EPS (Basic) figures stand at -$6.19 (Q1 2026), -$7.8 (Q4 2025), and -$13.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 BioAtla 5.74 Mn 5.74 Mn - -6.19

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.19
Dec 31, 2025 -7.80
Sep 30, 2025 -13.00
Jun 30, 2025 -22.45
Mar 31, 2025 -15.02
Dec 31, 2024 -16.16
Sep 30, 2024 -12.26
Jun 30, 2024 -23.61
Mar 31, 2024 -491.68
Dec 31, 2023 -28.44
Sep 30, 2023 -35.68
Jun 30, 2023 -140.43
Mar 31, 2023 -29.27
Dec 31, 2022 -35.85
Sep 30, 2022 -3,677.69
Jun 30, 2022 -121.69
Mar 31, 2022 -33.01
Dec 31, 2021 -34.38
Sep 30, 2021 -33.81
Jun 30, 2021 -45.10